{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:04:25Z","timestamp":1783987465897,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00508-015-0758-y","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T11:26:38Z","timestamp":1428578798000},"page":"619-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management","Neue Kriterien f\u00fcr Diagnostik und Management der Tuber\u00f6sen Sklerose"],"prefix":"10.1007","volume":"127","author":[{"name":"P\u00e4diatrisches TSC-Zentrum Wien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Samueli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Groeppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Jonak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Muehlebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Prayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,10]]},"reference":[{"issue":"5327","key":"758_CR1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Slegtenhorst van","year":"1997","unstructured":"van Slegtenhorst M, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277(5327):805\u20138.","journal-title":"Science"},{"issue":"7","key":"758_CR2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75(7):1305\u201315.","journal-title":"Cell"},{"issue":"1","key":"758_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2001;68(1):64\u201380.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"758_CR4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, et al. Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet. 1999;64(5):1305\u201315.","journal-title":"Am J Hum Genet"},{"key":"758_CR5","doi-asserted-by":"crossref","unstructured":"Lasarge CL, Danzer SC. Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front Mol Neurosci. 2014;7:18.","DOI":"10.3389\/fnmol.2014.00018"},{"issue":"21","key":"758_CR6","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee AR, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A. 2002;99(21):13571\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9114","key":"758_CR7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","volume":"351","author":"FJ O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan FJ, et al. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998;351(9114):1490.","journal-title":"Lancet"},{"issue":"9639","key":"758_CR8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657\u201368.","journal-title":"Lancet"},{"issue":"5","key":"758_CR9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1067\/S0022-3476(03)00494-3","volume":"143","author":"RS Bader","year":"2003","unstructured":"Bader RS, et al. Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr. 2003;143(5):620\u20134.","journal-title":"J Pediatr"},{"issue":"4","key":"758_CR10","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1542\/peds.2006-0504","volume":"118","author":"S Jozwiak","year":"2006","unstructured":"Jozwiak S, et al. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics. 2006;118(4):e1146\u201351.","journal-title":"Pediatrics"},{"issue":"2","key":"758_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-014-1429-y","volume":"118","author":"A Rovira","year":"2014","unstructured":"Rovira A, et al. Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex. J Neurooncol. 2014;118(2):205\u201323.","journal-title":"J Neurooncol"},{"issue":"8","key":"758_CR12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00234-013-1184-3","volume":"55","author":"AM Eeghen van","year":"2013","unstructured":"van Eeghen AM, et al. The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines. Neuroradiology. 2013;55(8):1007\u201314.","journal-title":"Neuroradiology"},{"issue":"7","key":"758_CR13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu-Shore","year":"2010","unstructured":"Chu-Shore CJ, et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51(7):1236\u201341.","journal-title":"Epilepsia"},{"issue":"10","key":"758_CR14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/088307380001501003","volume":"15","author":"S Jozwiak","year":"2000","unstructured":"Jozwiak S, et al. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol. 2000;15(10):652\u20139.","journal-title":"J Child Neurol"},{"issue":"6","key":"758_CR15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/adc.2003.026815","volume":"89","author":"FJ O\u2019Callaghan","year":"2004","unstructured":"O\u2019Callaghan FJ, et al. The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child. 2004;89(6):530\u20133.","journal-title":"Arch Dis Child"},{"issue":"7","key":"758_CR16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0387-7604(01)00300-X","volume":"23","author":"P Curatolo","year":"2001","unstructured":"Curatolo P, et al. Infantile spasms in tuberous sclerosis complex. Brain Dev. 2001;23(7):502\u20137.","journal-title":"Brain Dev"},{"issue":"4","key":"758_CR17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.yebeh.2011.08.037","volume":"22","author":"R Cusmai","year":"2011","unstructured":"Cusmai R, et al. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav. 2011;22(4):735\u20139.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"758_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00787-005-0443-1","volume":"14","author":"P Vries de","year":"2005","unstructured":"de Vries P, et al. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis. Eur Child Adolesc Psychiatry. 2005;14(4):183\u201390.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"758_CR19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejpn.2012.12.008","volume":"17","author":"S Jozwiak","year":"2013","unstructured":"Jozwiak S, Nabbout R, Curatolo P. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol. 2013;17(4):348\u201352.","journal-title":"Eur J Paediatr Neurol"},{"issue":"9861","key":"758_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2013;381(9861):125\u201332.","journal-title":"Lancet"},{"issue":"4","key":"758_CR21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40263-014-0139-5","volume":"28","author":"R Riikonen","year":"2014","unstructured":"Riikonen R. Recent advances in the pharmacotherapy of infantile spasms. CNS Drugs. 2014;28(4):279\u201390.","journal-title":"CNS Drugs"},{"key":"758_CR22","doi-asserted-by":"crossref","unstructured":"Jones K, et al. Adrenocorticotropic Hormone Versus Prednisolone in the Treatment of Infantile Spasms Post Vigabatrin Failure. J Child Neurol. 2014 Jun 25. pii: 0883073814533148. Epub ahead of print.","DOI":"10.1177\/0883073814533148"},{"issue":"8","key":"758_CR23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1528-1167.2007.01117.x","volume":"48","author":"FE Jansen","year":"2007","unstructured":"Jansen FE, et al. Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia. 2007;48(8):1477\u201384.","journal-title":"Epilepsia"},{"issue":"5","key":"758_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.seizure.2007.03.001","volume":"16","author":"FE Jansen","year":"2007","unstructured":"Jansen FE, et al. Epilepsy surgery in tuberous sclerosis: the Dutch experience. Seizure. 2007;16(5):445\u201353.","journal-title":"Seizure"},{"issue":"4","key":"758_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ejpn.2013.12.006","volume":"18","author":"D Domanska-Pakiela","year":"2014","unstructured":"Domanska-Pakiela D, et al. EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients-A prospective study of 5 patients. Eur J Paediatr Neurol. 2014;18(4):458\u201368.","journal-title":"Eur J Paediatr Neurol"},{"key":"758_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.1991.tb37744.x","volume":"615","author":"DM Robertson","year":"1991","unstructured":"Robertson DM. Ophthalmic manifestations of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:17\u201325.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"758_CR27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.85.4.420","volume":"85","author":"SA Rowley","year":"2001","unstructured":"Rowley SA, O\u2019Callaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol. 2001;85(4):420\u20133.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"758_CR28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/08830738040190091001","volume":"19","author":"DN Franz","year":"2004","unstructured":"Franz DN. Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol. 2004;19(9):690\u20138.","journal-title":"J Child Neurol"},{"issue":"2","key":"758_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0420.2006.00781.x","volume":"85","author":"S Mennel","year":"2007","unstructured":"Mennel S, et al. Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand. 2007;85(2):127\u201332.","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"758_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au KS, et al. Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007;9(2):88\u2013100.","journal-title":"Genet Med"},{"issue":"3","key":"758_CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0883073807309250","volume":"23","author":"AN Datta","year":"2008","unstructured":"Datta AN, Hahn CD, Sahin M. Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J Child Neurol. 2008;23(3):268\u201373.","journal-title":"J Child Neurol"},{"issue":"12","key":"758_CR32","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-4362.1998.00495.x","volume":"37","author":"S Jozwiak","year":"1998","unstructured":"Jozwiak S, et al. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998;37(12):911\u20137.","journal-title":"Int J Dermatol"},{"issue":"1","key":"758_CR33","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1542\/peds.2010-0192","volume":"127","author":"BA Staley","year":"2011","unstructured":"Staley BA, Vail EA, Thiele EA. Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics. 2011;127(1):e117\u201325.","journal-title":"Pediatrics"},{"issue":"11","key":"758_CR34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/adc.2011.211995","volume":"96","author":"JR Yates","year":"2011","unstructured":"Yates JR, et al. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child. 2011;96(11):1020\u20135.","journal-title":"Arch Dis Child"},{"issue":"1","key":"758_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1996.tb03597.x","volume":"135","author":"DW Webb","year":"1996","unstructured":"Webb DW, et al. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135(1):1\u20135.","journal-title":"Br J Dermatol"},{"issue":"4","key":"758_CR36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","volume":"49","author":"H Northrup","year":"2013","unstructured":"Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49(4):243\u201354.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"758_CR37","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","volume":"23","author":"ME Tyburczy","year":"2014","unstructured":"Tyburczy ME, et al. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. Hum Mol Genet. 2014;23(8):2023\u20139.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"758_CR38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-0960.2011.00837.x","volume":"53","author":"RS Foster","year":"2012","unstructured":"Foster RS, Bint LJ, Halbert AR. Topical 0.1\u2009% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients. Australas J Dermatol. 2012;53(1):52\u20136.","journal-title":"Australas J Dermatol"},{"issue":"4","key":"758_CR39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","volume":"165","author":"M Wataya-Kaneda","year":"2011","unstructured":"Wataya-Kaneda M, et al. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity. Br J Dermatol. 2011;165(4):912\u20136.","journal-title":"Br J Dermatol"},{"issue":"8","key":"758_CR40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","volume":"66","author":"CW Shepherd","year":"1991","unstructured":"Shepherd CW, et al. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. 1991;66(8):792\u20136.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"758_CR41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","volume":"94","author":"FJ O\u2019Callaghan","year":"2004","unstructured":"O\u2019Callaghan FJ, et al. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 2004;94(6):853\u20137.","journal-title":"BJU Int"},{"issue":"10","key":"758_CR42","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, et al. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006;70(10):1777\u201382.","journal-title":"Kidney Int"},{"issue":"1","key":"758_CR43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","volume":"160","author":"DH Ewalt","year":"1998","unstructured":"Ewalt DH, et al. Renal lesion growth in children with tuberous sclerosis complex. J Urol. 1998;160(1):141\u20135.","journal-title":"J Urol"},{"issue":"4","key":"758_CR44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","volume":"61","author":"JR Sampson","year":"1997","unstructured":"Sampson JR, et al. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet. 1997;61(4):843\u201351.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"758_CR45","first-page":"1201","volume":"149","author":"J Bjornsson","year":"1996","unstructured":"Bjornsson J, et al. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol. 1996;149(4):1201\u20138.","journal-title":"Am J Pathol"},{"issue":"5","key":"758_CR46","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-3468(96)90689-2","volume":"31","author":"FM Robertson","year":"1996","unstructured":"Robertson FM, et al. Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg. 1996;31(5):729\u201330.","journal-title":"J Pediatr Surg"},{"issue":"4","key":"758_CR47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-4295(91)80261-5","volume":"37","author":"R Washecka","year":"1991","unstructured":"Washecka R, Hanna M. Malignant renal tumors in tuberous sclerosis. Urology. 1991;37(4):340\u20133.","journal-title":"Urology"},{"issue":"4","key":"758_CR48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ndt\/14.4.988","volume":"14","author":"A Clarke","year":"1999","unstructured":"Clarke A, et al. End-stage renal failure in adults with the tuberous sclerosis complex. Nephrol Dial Transplant. 1999;14(4):988\u201391.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"758_CR49","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1159\/000320891","volume":"118","author":"BP Dixon","year":"2011","unstructured":"Dixon BP, Hulbert JC, Bissler JJ. Tuberous sclerosis complex renal disease. Nephron Exp Nephrol. 2011;118(1):e15\u2013e20.","journal-title":"Nephron Exp Nephrol"},{"key":"758_CR50","doi-asserted-by":"crossref","unstructured":"Bridle KR, et al. Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2 mice. Liver Int. 2014 Feb 11. doi:10.1111\/liv.12494. Epub ahead of print.","DOI":"10.1111\/liv.12494"},{"issue":"5","key":"758_CR51","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1200\/JCO.2012.44.5106","volume":"31","author":"C Rothermundt","year":"2013","unstructured":"Rothermundt C, Gillessen S. Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor. J Clin Oncol. 2013;31(5):e57\u20138.","journal-title":"J Clin Oncol"},{"issue":"9869","key":"758_CR52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013;381(9869):817\u201324.","journal-title":"Lancet"},{"issue":"1","key":"758_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/rmed.2001.1207","volume":"96","author":"E Hancock","year":"2002","unstructured":"Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med. 2002;96(1):1\u20136.","journal-title":"Respir Med"},{"issue":"9","key":"758_CR54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2004.023283","volume":"59","author":"SR Johnson","year":"2004","unstructured":"Johnson SR, et al. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax. 2004;59(9):800\u20133.","journal-title":"Thorax"},{"issue":"119","key":"758_CR55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1183\/09059180.00011010","volume":"20","author":"S Harari","year":"2011","unstructured":"Harari S, Torre O, Moss J. Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev. 2011;20(119):34\u201344.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"758_CR56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20131080","volume":"211","author":"C Li","year":"2014","unstructured":"Li C, et al. Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med. 2014;211(1):15\u201328.","journal-title":"J Exp Med"},{"issue":"1","key":"758_CR57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jmg.37.1.55","volume":"37","author":"A Astrinidis","year":"2000","unstructured":"Astrinidis A, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet. 2000;37(1):55\u20137.","journal-title":"J Med Genet"},{"issue":"7","key":"758_CR58","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","volume":"167","author":"M Karbowniczek","year":"2003","unstructured":"Karbowniczek M, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med. 2003;167(7):976\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"758_CR59","first-page":"691","volume":"10","author":"KF Xu","year":"2014","unstructured":"Xu KF, Lo BH. Lymphangioleiomyomatosis: differential diagnosis and optimal management. Ther Clin Risk Manag. 2014;10:691\u2013700.","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"758_CR60","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","volume":"190","author":"J Yao","year":"2014","unstructured":"Yao J, et al. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2014;190(11):1273\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"758_CR61","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/adc.67.11.1363","volume":"67","author":"S Jozwiak","year":"1992","unstructured":"Jozwiak S, et al. Incidence of hepatic hamartomas in tuberous sclerosis. Arch Dis Child. 1992;67(11):1363\u20135.","journal-title":"Arch Dis Child"},{"issue":"4","key":"758_CR62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):255\u201365.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"758_CR63","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00467-010-1466-5","volume":"25","author":"AE Salerno","year":"2010","unstructured":"Salerno AE, et al. Vascular involvement in tuberous sclerosis. Pediatr Nephrol. 2010;25(8):1555\u201361.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"758_CR64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.braindev.2008.09.013","volume":"31","author":"V Napolioni","year":"2009","unstructured":"Napolioni V, Moavero R, Curatolo P. Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev. 2009;31(2):104\u201313.","journal-title":"Brain Dev"},{"issue":"12","key":"758_CR65","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00381-013-2170-0","volume":"29","author":"AM Cappellano","year":"2013","unstructured":"Cappellano AM, et al. Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex. Childs Nerv Syst. 2013;29(12):2301\u20135.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"758_CR66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00381-014-2383-x","volume":"30","author":"T Ouyang","year":"2014","unstructured":"Ouyang T, et al. Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst. 2014;30(4):561\u201370.","journal-title":"Childs Nerv Syst"},{"key":"758_CR67","doi-asserted-by":"crossref","unstructured":"Kaplan B, Qazi Y, Wellen JR. Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev. 2014 Jul;28(3):126\u201333. doi:10.1016\/j.trre.2014.03.002. Epub 2014 Mar 12.","DOI":"10.1016\/j.trre.2014.03.002"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-015-0758-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-015-0758-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-015-0758-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T19:00:49Z","timestamp":1651690849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-015-0758-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,10]]},"references-count":67,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s00508-015-0758-y","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,10]]}}}